In This Article:
- By insider
President & CEO of Medpace Holdings Inc (MEDP) August J. Troendle sold 114,983 shares of MEDP on 09/20/2018 at an average price of $59.31 a share. The total sale was $6.8 million.
Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings Inc has a market cap of $2.06 billion; its shares were traded at around $57.90 with a P/E ratio of 41.64 and P/S ratio of 3.87.
-
Warning! GuruFocus has detected 2 Warning Sign with INGN. Click here to check it out.
-
The intrinsic value of MEDP
CEO Recent Trades:
-
President & CEO, 10% Owner August J. Troendle sold 114,983 shares of MEDP stock on 09/20/2018 at the average price of $59.31. The price of the stock has decreased by 2.38% since.
Directors and Officers Recent Trades:
-
10% Owner Investors, Llc Medpace sold 114,983 shares of MEDP stock on 09/20/2018 at the average price of $59.31. The price of the stock has decreased by 2.38% since.
-
10% Owner Limited Partnership Medpace sold 5,224,997 shares of MEDP stock on 08/27/2018 at the average price of $54.75. The price of the stock has increased by 5.75% since.
For the complete insider trading history of MEDP, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 2 Warning Sign with INGN. Click here to check it out.
-
The intrinsic value of MEDP